Sponsor:
University of Miami
Code:
NCT03135327
Conditions
Multiple Sclerosis
Dry Eye Syndromes
Diabetic Retinopathy
Presbyopia
Myopia
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Ocufolin
Brief summary:
Conditions
Multiple Sclerosis
Dry Eye Syndromes
Diabetic Retinopathy
Presbyopia
Myopia
Study ID
NCT03135327
Start date
Jan 1, 2007
Status verified date
Aug, 2025
Completion date
Dec 31, 2029
Anticipated
Primary completion date
Dec 31, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
5000 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Interventional Phase - Ocufolin Group
no intervention: Observational Phase Group
Interventions
Ocufolin
Primary outcome measure
Central contacts
Locations
Bascom Palmer Eye Institute
Recruiting
Miami, Florida, United States, 33136
Contacts
Principal Investigator:
Jianhua Wang, MD, PhD
Sponsor
University of Miami
Last update posted
Aug 12, 2025
Last verified
Aug, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Miami on 2025-08-12.